Company intelligence / Profile preview

Fleni

Buenos Aires, Buenos Aires, Argentinafleni.org.ar ↗

Ownership: Private
Employees: ~1585
Development stage: Commercial

Overview

Fleni provides comprehensive medical services focused on neurology, neurosurgery, rehabilitation, and advanced neuroscience research. It has developed human induced pluripotent stem cell lines from patients with Down syndrome for use in neurodegeneration studies. The institution also offers specialized diagnostic imaging and intensive rehabilitation programs. Its mission emphasizes excellence in patient care alongside robust academic activity.

Therapeutic areas: Neurology
Modalities: Cell therapyNon-pharmacological therapy
Industry: Academic Hospital/University/Research

Partnerships

Academic collaborations are frequent

Beyond the preview

Go deeper on Fleni.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fleni.

Explore the full profile